Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension
Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension
Enrolling by invitation · NCT07064525 · Registry updated 2025-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension | Nutritional and Metabolic Diseases, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, vascular disorder | Enrolling by invitation | Phase 2 | 2025-07-14 | NCT07064525 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shin Poong Pharmaceutical Co. Ltd. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHA Gangnam Medical Center, CHA University | Seoul | South Korea | 1 |